Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 2Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2Venous Thromboembolism 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Venous Thormboembolism 1Thrombosis 1Small Cell Lung Carcinoma 1Pulmonary Embolism 1Colorectal Neoplasms 1Catheter-Related Infections 1Carcinoma, Pancreatic Ductal 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Enoxaparin × Clear all
NCT00633061 2020-10-08

DVT

University of Texas Southwestern Medical Center

Phase 2 Terminated
136 enrolled 6 charts

Neoplasms, Venous Thrombosis, Catheter-Related Infections

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡